过去一年中添加的文章，按日期排序
Obesity-Associated Breast Cancer: Analysis of Risk Factors and Current Clinical Evaluation
A Engin - Advances in experimental medicine and …, 2024 - pubmed.ncbi.nlm.nih.gov
3 天前 - … Additionally, obese and postmenopausal women … patients who have clinically
axillary lymph node-positive to node-negative conversion following neoadjuvant chemotherapy is …
axillary lymph node-positive to node-negative conversion following neoadjuvant chemotherapy is …
… and Future Prospects of Human Epidermal Growth Factor Receptor 2 (HER2) and Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted Antibody-Drug Conjugates in …
X Gao, T Bu, W Wang, Y Xu - Breast Cancer: Targets and Therapy, 2024 - Taylor & Francis
4 天前 - … has shown efficacy in targeting hypoxic cells and enhancing the … chemotherapy
in breast cancer models. Citation24 Additionally, combining tirapazamine with HER2-targeted …
in breast cancer models. Citation24 Additionally, combining tirapazamine with HER2-targeted …
… Risk of Adverse Prognosis in Patients with T2-3 Stage Breast Cancer Exhibiting Non-Pathological Complete Response Following Neoadjuvant Chemotherapy …
F Li, CG Chen, JF Wei, JW Lin, ZA Dou… - … Cancer: Targets and …, 2024 - Taylor & Francis
10 天前 - … following neoadjuvant chemotherapy (NACT). Additionally, we examined the
potential correlation and interaction between Reg IV and epidermal growth factor receptor (EGFR). …
potential correlation and interaction between Reg IV and epidermal growth factor receptor (EGFR). …
[HTML][HTML] Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer
M Calheiros-Lobo, JPN Silva, B Pinto, L Monteiro… - Pharmaceutics, 2024 - mdpi.com
10 天前 - … chemotherapy is one of the most widely used treatments for HNSCC, a monoclonal
antibody that targets the epidermal growth factor receptor (… In addition to blocking EGFR …
antibody that targets the epidermal growth factor receptor (… In addition to blocking EGFR …
Clinicopathological factors predicting pathological complete response to neoadjuvant anti-HER2 therapy in HER2-positive breast cancer
YJ Jung, S Lee, SK Kang, JY Kim, KS Choo, KJ Nam… - Oncology, 2024 - karger.com
12 天前 - … Human epidermal growth factor receptor 2 (HER2)-targeted … This makes neoadjuvant
chemotherapy (NAC) a valuable … Additionally, two patients with occult breast cancer who …
chemotherapy (NAC) a valuable … Additionally, two patients with occult breast cancer who …
[HTML][HTML] Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review
AM Sanwick, IF Chaple - Frontiers in Oncology, 2024 - ncbi.nlm.nih.gov
15 天前 - … In addition to the drawbacks of chemotherapy and radiation therapy… additional
treatment option, to improve patient outcomes and quality of life. Epidermal growth factor receptor …
treatment option, to improve patient outcomes and quality of life. Epidermal growth factor receptor …
Epidermal growth factor receptor-mutated lung carcinomas with insufficient response to epidermal growth factor receptor inhibitors
F Moiseenko, E Kuligina, E Elsakova… - Future Oncology, 2024 - Taylor & Francis
18 天前 - … may involve the addition of chemotherapy and antiangiogenic drugs to patients,
who … Although initially the concept of NSCLC targeted therapy looked relatively simple and …
who … Although initially the concept of NSCLC targeted therapy looked relatively simple and …
[引用][C] 233MO Ovarian function suppression in HR-positive, HER2-positive breast cancer: An exploratory analysis from the HERA trial
S Moon, SJ Bae, Y Kook, BS Ho, L Minji… - Annals of …, 2024 - annalsofoncology.org
20 天前 - … -positive, human epidermal growth factor receptor 2 (HER2)… Our results support the
addition of OFS to antihormonal … are undergoing chemotherapy and HER2-targeted therapy. …
addition of OFS to antihormonal … are undergoing chemotherapy and HER2-targeted therapy. …
[PDF][PDF] Expression profile of messenger and micro RNAs related to the histaminergic system in patients with five subtypes of breast cancer
T Sirek, A Sirek, M Opławski, D Boroń… - Frontiers in …, 2024 - researchgate.net
23 天前 - … epidermal growth factor receptor 2-… targeting the histaminergic system, thereby
offering potential improvements in the treatment and management of breast cancer. Additionally, …
offering potential improvements in the treatment and management of breast cancer. Additionally, …
[HTML][HTML] … and physicians' insights on Chinese patients with advanced non-small cell lung cancer habouring epidermal growth factor receptor 20 insertion mutation
Y Shi, Y Xu, M Wang - BMC cancer, 2024 - Springer
29 天前 - … We also added novel EGFR exon20ins-targeted agents … In addition, we
added a question to investigate the factors … choices are chemotherapy and chemotherapy-based …
added a question to investigate the factors … choices are chemotherapy and chemotherapy-based …